BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2006

View Archived Issues

Vascular endothelial growth factor antisense active, well tolerated in cancer patients

Read More

Antiinfluenza activity of traditional Korean medicinal herb extracts

Read More

A role for Omi/HtrA2 in skin inflammation following UVB irradiation

Read More

Alnylam licenses RNAi delivery technology from CBR Institute

Read More

DepoMed finalizes phase III protocol for Gabapentin GR study

Read More

M.D. Anderson Cancer Center spearheading new brain tumor treatments

Read More

Animal models reveal anti-infective efficacy of REP-9

Read More

Experiments show potential of ST-246 against orthopoxvirus infection

Read More

PharmaFrontiers presents data on T-cell and stem cell technology

Read More

Effects on biomarkers point to R-115866 activity in acne

Read More

Angiotech and Genzyme collaborate on innovative surgical oncology treatments

Read More

Qnexa produces weight loss in phase II study

Read More

NG2-73 significantly reduces time to onset of persistent sleep

Read More

CCR5 antagonist INCB-9471 begins phase I study

Read More

CTA-002 produces tumor suppression in prostate cancer model

Read More

New phase I/II study evaluating picoplatin for colorectal cancer

Read More

Laureate Pharma and Iconic Therapeutics sign hI-con1 manufacturing agreement

Read More

NephroGenex licenses Pyridorin rights

Read More

Fast track designation for Cell Genesys' GVAX immunotherapy for prostate cancer

Read More

Diatos acquires rights to DaunoXome

Read More

Elocalcitol shows efficacy in overactive bladder phase II study

Read More

Vanadium complex with insulin-mimetic activities

Read More

SurModics grants Bausch & Lomb genistein license in retinal diseases

Read More

Fast track status for BiovaxID

Read More

Recent patents report novel analgesic agents

Read More

Novel agents for treating neurological disorders disclosed in recent patent literature

Read More

Recent patents describe new diabetic treatment options

Read More

Taisho reports preclinical data on prostanoid receptor agonist for atopic dermatitis

Read More

New foscarnet derivative with activity against resistant HIV reported by Chimerix

Read More

Novel HIV-1 protease inhibitor demonstrates efficacy and good cross-resistance profile in vitro

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 23, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 21, 2026
  • Green arrow on blue abstract background

    Psychedelic space expanding on Trump’s EO

    BioWorld
    Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
  • Illustration of metastatic cancer

    At AACR: Epigenetic fingerprints in metastases track tumor origin

    BioWorld
    When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
  • In the clinic for April 21, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing